How many acquisitions has Gilead made so far?

Gilead has completed 21 acquisitions so far, with an average acquisition amount of $3.33B.

Which countries does Gilead usually acquire in?

Gilead has made acquisitions in 5 countries with the most activity in United States and Germany.

Which sectors does Gilead target for acquisitions?

Most of Gilead's acquisitions are in Oncology (14) and Immunotherapy (8).

List of 21 Acquisitions by Gilead (Oct 2026)

Q: Which is Gilead's latest acquisition?

Gilead's most recent acquisition is Tubulis Technologies, a Developer of antibody-drug conjugates for the treatment of cancer, acquired in April 2026.

Gilead has made a total of 21 acquisitions. The organization has focused its activity across 11 sectors, including Oncology, Immunotherapy, and Infectious Diseases, spanning 5 countries, specifically United States, Germany, and United Kingdom. Peak acquisition years included 3 in 2026, 3 in 2020, and 2 in 2017. The average number of acquisitions per year from 2020–2025 is 0.6, and 3 acquisitions have been completed in the current calendar year. The most recent acquisition is Tubulis Technologies, a developer of antibody-drug conjugates for cancer treatment. Founded in 2015 and based in Munich, the company was acquired in April 2026.

Here's the year on year acquisition history of Gilead:

Number of Total Acquisitions

Year	# Acquisitions
2026	3
2024	1
2023	1
2022	1
2020	3
2017	2
2015	1
2012	1
2011	2
2010	2
2009	1
2006	2
2002	1

View all Acquisitions by Gilead

Recent acquisitions by Gilead

Gilead's most recent acquisition - Tubulis Technologies is a Developer of antibody-drug conjugates for the treatment of cancer, founded in 2015 and located in Munich. Gilead acquired it in April 2026 for a price of $*****.

Here is the list of all acquisitions by Gilead sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Apr 07, 2026	Tubulis Technologies	szeh	ytty	60	907
Mar 23, 2026	Ouro Medicines	aykd	ffog	78	441
Feb 23, 2026	Arcellx	ojlm	cniu	94	551
Feb 12, 2024	CymaBay Therapeutics	dcec	igsj	52	377
May 01, 2023	XinThera	rzsm	sm{w	81	709